Filtered news list testing
List of Reports
.pdf
07/24/2025 - H1 2025 Revenue
.pdf
04/28/25 - Universal Registration Document 2024
.pdf
04/24/25 - Q1 2025 revenue
.pdf
03/27/2025 - 2024 Full-year results (Presentation)
.pdf
03/26/2025 - 2024 full-year results
.pdf
02/06/2025 - 2024 revenue
.pdf
01/13/2025 - GUERBET Financial Agenda 2025
.pdf
10/30/2024 - GUERBET Blackout Periods Calendar 2025
Single report testing
.pdf
test report fabien V 09-07
Separator
Filtered images
Discover the latest news of Guerbet
Latest news
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
2024 revenue
2024 revenue
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging